Information Provided By: 
Fly News Breaks for March 27, 2019
JAZZ
Mar 27, 2019 | 05:38 EDT
Mizuho analyst Irina Koffler raised her price target for Jazz Pharmaceuticals to $147 from $137 to reflect the recent approval of Sunosi and last night's positive data in the Phase III trial of JZP-258. However, both of these events were largely expected, Koffler tells investors in a research note. She reiterates a Neutral rating on Jazz Pharmaceuticals.
News For JAZZ From the Last 2 Days
There are no results for your query JAZZ
